Director TitleAgeSince
Chairman - -
Chairman - 2012-06-27
Director/Board Member - 2012-12-23
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
+0.70%+4.78%+0.38%+13.66% 49.37B
-3.95%+14.70%+24.15%+5.15% 39.14B
+6.22%+1.81%+419.17%+647.45% 40.85B
-1.57%-1.44%+7.38%+43.06% 35.81B
+5.56%+11.70%+11.64%+51.50% 30.5B
-0.39%-0.63% - - 16.55B
-1.13%-4.54%+32.10%+126.95% 16.14B
-7.10%-2.81%-8.80%-34.35% 12.77B
+0.35%+3.61%+2.20%+9.94% 13.71B
Average -0.02%+6.06%+61.03%+107.92% 28.32B
Weighted average by Cap. +0.51%+7.02%+80.34%+135.07%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock